SUNNYVALE, Calif., April 29 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today announced that the United States Postal Service (USPS)
yesterday issued a press release stating that further deployment of the
Biohazard Detection System (BDS) is being temporarily delayed. In the process
of the recently initiated production deployment of the BDS, selected mail
sorting lines representing only a small number of the total systems deployed
at this time began to experience an increase in the rate of non-determinant
tests. As noted in the USPS press release, a non-determinant test does not
indicate a threat is suspected. It simply means that the test did not provide
an answer.
"It is not unexpected that a new program may run into unique issues during
initial deployment. What is important is to maintain an objective and
scientifically valid analysis of issues as they arise in order to minimize or
eliminate further issues as deployment proceeds. Cepheid is actively working
with Northop Grumman and the USPS in addressing this particular issue and
looks forward to continue working as an effective team member now and in the
future," stated John L. Bishop, Chief Executive Officer.
About Cepheid
Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is a leading
developer, manufacturer and marketer of fully integrated systems that enable
genetic assessment when and where it is needed. Founded in 1996, the company
is commercializing its technology and products worldwide for research,
medical, and industrial applications requiring assessment of the human genome,
infectious disease and biothreat agents. See http://www.cepheid.com for more
information.
This press release contains forward-looking statements that are not purely
historical regarding Cepheid's or its management's intentions, beliefs,
expectations and strategies for the future, including those relating to the
deployment of the BDS. Because such statements deal with future events, they
are subject to various risks and uncertainties, and actual results could
differ materially from the company's current expectations. Factors that could
cause actual results to differ materially include risks and uncertainties such
as those relating to governmental spending priorities or program parameters,
or whether the BDS performs to specifications. Readers should also refer to
the section entitled "Risk Factors" in Cepheid's Annual Report on Form 10-K
for 2003.
All forward-looking statements and reasons why results might differ
included in this release are made as of the date of this press release, based
on information currently available to Cepheid, and Cepheid assumes no
obligation to update any such forward-looking statement or reasons why results
might differ.
For further information, please contact John L. Bishop, CEO,
bishop@cepheid.com, or John R. Sluis, CFO, sluis@cepheid.com, both of Cepheid,
+1-408-541-4191; or Media, Cynthia Martin, +1-312-640-6741,
cmartin@financialrelationsboard.com, or Investor/Analyst Information, Tricia
Ross, +1-310-407-6540, tross@financialrelationsboard.com, both of Financial
Relations Board, for Cepheid.
| |
SOURCE Cepheid
 back to top
Related links:
http://www.cepheid.com
CONTACT:
John L. Bishop, CEO, bishop@cepheid.com, or
John R. Sluis, CFO, sluis@cepheid.com, both of Cepheid,
+1-408-541-4191; or Media, Cynthia Martin, +1-312-640-6741,
cmartin@financialrelationsboard.com, or Investor/Analyst
Information, Tricia Ross, +1-310-407-6540,
tross@financialrelationsboard.com, both of Financial Relations
Board, for Cepheid
| |
|
